Skip to main content
. Author manuscript; available in PMC: 2020 Aug 21.
Published in final edited form as: Horm Metab Res. 2016 May 12;48(8):509–513. doi: 10.1055/s-0042-106725

Table 4.

Follow-up data.

Patient number 1 2 3 4 5 6 7 8 9
Type of surgery Multiple pelvic tumors resected Right adrenalectomy Removal of retroperitoneal PGL Right extra adrenal PGL Aortocaval PGL Bilateral adrenalectomy Left adrenalectomy Multiple Para aortic PGLs removed Multiple PGLs in thorax removed
Time elapsed from surgery to most recent follow-up (years) 3.2 2.0 2.8 2.0 2.0 2.4 1.5 1.6 1.3
Catecholamine and metanephrines values at most recent follow-up NMN 2.2 X ULN NE 1.2 X ULN MN 1.8×ULN WNL WNL WNL WNL Not done WNL NE1.6×ULN D 2×ULN NMN 2.8×ULN MN 2.3×ULN D 1.2×ULN
Pheo/Para status at follow-up? (Remission, Metastatic, etc.) Small metastatic pelvic lesion Remission Remission Remission Remission Remission Remission Widespread skeletal disease+metastatic lymph nodes Retroperitoneal mass skeletal metastases
Symptoms of inattention, hyperactivity, impulsivity Resolution of ADHD Persistence of symptoms of inattention and aggression Persistence of ADHD Resolution of ADHD Resolution of ADHD Improvement of ADHD Continues to have panic attacks and anxiety Persistence of ADHD and coexisting neuro-developmental delay Persistence of ADHD
On ADHD meds at time of post-surgical follow-up? No No Amphetamine salts, Guanfacine No No No No No Atomoxetine